CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended				6 Months Ended
	Jun. 29, 2014		Jun. 30, 2013		Jun. 29, 2014		Jun. 30, 2013
Income Statement [Abstract]
Revenues	$ 12,773		$ 12,973		$ 24,126		$ 25,383
Costs and expenses:
Cost of sales(a)	2,462	[1]	2,242	[1]	4,507	[1]	4,505	[1]
Selling, informational and administrative expenses(a)	3,520	[1]	3,591	[1]	6,560	[1]	6,808	[1]
Research and development expenses(a)	1,759	[1]	1,530	[1]	3,382	[1]	3,240	[1]
Amortization of intangible assets	1,001		1,140		2,118		2,359
Restructuring charges and certain acquisition-related costs	81		183		139		314
Other (income)/deductions––net	(53)		(1,070)		570		(925)
Income from continuing operations before provision for taxes on income	4,003	[2]	5,357	[2]	6,850	[2]	9,082	[2]
Provision for taxes on income	1,082		1,782		1,664		2,891
Income from continuing operations	2,921		3,575		5,186		6,191
Discontinued operations:
Income from discontinued operations––net of tax	(2)		141		3		290
Gain on disposal of discontinued operations––net of tax	2	[3]	10,418	[3]	70	[3]	10,418	[3]
Discontinued operations––net of tax	0		10,559		73		10,708
Net income before allocation to noncontrolling interests	2,921		14,134		5,259		16,899
Less: Net income attributable to noncontrolling interests	9		39		18		54
Net income attributable to Pfizer Inc.	$ 2,912		$ 14,095		$ 5,241		$ 16,845
Earnings per common share––basic(b):
Income from continuing operations attributable to Pfizer Inc. common shareholders	$ 0.46	[4]	$ 0.51	[4]	$ 0.81	[4]	$ 0.87	[4]
Discontinued operations––net of tax	$ 0.00	[4]	$ 1.50	[4]	$ 0.01	[4]	$ 1.50	[4]
Net income attributable to Pfizer Inc. common shareholders	$ 0.46	[4]	$ 2.00	[4]	$ 0.82	[4]	$ 2.37	[4]
Earnings per common share––diluted(b):
Income from continuing operations attributable to Pfizer Inc. common shareholders	$ 0.45	[4]	$ 0.50	[4]	$ 0.80	[4]	$ 0.86	[4]
Discontinued operations––net of tax	$ 0.00	[4]	$ 1.48	[4]	$ 0.01	[4]	$ 1.49	[4]
Net income attributable to Pfizer Inc. common shareholders	$ 0.45	[4]	$ 1.98	[4]	$ 0.81	[4]	$ 2.34	[4]
Weighted-average shares––basic	6,368		7,042		6,379		7,115
Weighted-average shares––diluted	6,444		7,117		6,460		7,185
Cash dividends paid per common share	$ 0.26		$ 0.24		$ 0.52		$ 0.48

[1] Excludes amortization of intangible assets, except as disclosed in Note 9B. Goodwill and Other Intangible Assets: Other Intangible Assets.

[2] Income from continuing operations before provision for taxes on income.

[3] For the three and six months ended June 29, 2014, represents post-close adjustments.

[4] EPS amounts may not add due to rounding.